Funding · Healthcare & Life Sciences

Ayati Devices raises ₹15 crore in pre-series a funding led by Inflexor Ventures

By Startup Enthusiast · 11 August 2026

What they do

Ayati Devices builds portable, affordable diagnostic tools for diabetic foot complications and vascular disease

The company raised ₹15 crore in a pre-series a round led by Inflexor Ventures to scale its diagnostic platform and expand globally

Ayati's technologies are already deployed in over 30 countries and have regulatory clearances in India, the U.S; europe, and other markets

Ayati Devices, a Bengaluru-based medical technology company, raised ₹15 crore in a pre-series A funding round led by Inflexor Ventures.
Ayati's portfolio includes products like Vibrasense, Vasosense, Angiocam, and the PODIA Trolley, which provide portable, point-of-care diagnostics for diabetic foot complications and vascular disease.
The company has deployed over 10,000 devices across 30+ countries and has regulatory clearances in India, the U.S., Europe, and other international markets.
Ayati's technologies are designed to bring advanced diagnostics to primary care centres and clinics, reducing the need for specialist facilities.

India's medical devices sector is growing rapidly, driven by innovation and government incentives, and Ayati is positioned to benefit from this trend.
Diabetic foot complications are a major health issue, with over 90 million Indians living with diabetes and 50,000 lower-limb amputations occurring annually in India.
Ayati's diagnostic tools are clinically validated and have been tested in studies showing high sensitivity and specificity for detecting peripheral neuropathy.

Ayati Devices focuses on developing portable, point-of-care diagnostic tools for diabetic foot complications and vascular disease.
The company's products include Vibrasense for nerve function assessment, Vasosense for vascular screening, Angiocam for tissue perfusion imaging, and the PODIA Trolley for pay-per-test screening.
Ayati's technologies are designed to be used in clinics, hospitals, and screening programs, making advanced diagnostics more accessible and affordable.
The company has deployed over 10,000 devices across 30+ countries and has regulatory clearances in India, the U.S., Europe, and other international markets.
Ayati's solutions are used by healthcare providers, including clinics, hospitals, and specialists such as diabetologists and podiatrists.

Ayati plans to expand its manufacturing capacity and strengthen its distribution network in India and overseas.
The company aims to develop AI capabilities that integrate data from multiple diagnostic tests for risk stratification and clinical decision support.
Ayati will evaluate direct commercial operations in key international markets as demand for its diagnostic tools grows.

Inflexor Ventures (lead) — A venture capital firm focused on early-stage technology and healthcare startups.

Product: Portable diagnostic devices (Vibrasense, Vibrasense+T, Vasosense, Angiocam) for assessing diabetic foot complications and peripheral vascular disease
Customers: Hospitals, clinics, primary care centers, and screening programs managing diabetic patients and vascular health
How it makes money: B2B hardware and software platform for medical device sales to healthcare providers
What sets it apart: Enables early screening for diabetic complications in non-tertiary settings with portable, point-of-care technology
Operations: Manufacturing of medical devices with deployment across clinics, hospitals and primary care networks